The Bio Report
The Bio Report

Stopping Shape-Shifting Tumors with a First-in-Class Epigenetic Drug

Epigenetics, the layer of chemical switches that controls how genes are turned on and off, can act like cancer’s operating system when a single epigenetic enzyme becomes essential for a tumor to survive. K36 Therapeutics is developing first‑in‑class medicines that block an epigenetic enzyme that hel

Featured Speakers

Levine Media Group Host
🔓 Sign Up for Unlimited Episode Search

About The Bio Report

The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.

View all episodes from The Bio Report